WO2015065100A1 - Spherical hydrogel particles using mpc and water-soluble crosslinking agent - Google Patents
Spherical hydrogel particles using mpc and water-soluble crosslinking agent Download PDFInfo
- Publication number
- WO2015065100A1 WO2015065100A1 PCT/KR2014/010359 KR2014010359W WO2015065100A1 WO 2015065100 A1 WO2015065100 A1 WO 2015065100A1 KR 2014010359 W KR2014010359 W KR 2014010359W WO 2015065100 A1 WO2015065100 A1 WO 2015065100A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mpc
- water
- spherical hydrogel
- oil
- emulsion
- Prior art date
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 84
- 239000002245 particle Substances 0.000 title claims abstract description 64
- 239000003431 cross linking reagent Substances 0.000 title claims abstract description 27
- 239000007864 aqueous solution Substances 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 12
- -1 methacryloyl phosphoryl Chemical group 0.000 claims abstract description 6
- 229950004354 phosphorylcholine Drugs 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 48
- 239000000243 solution Substances 0.000 claims description 26
- 239000004094 surface-active agent Substances 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 229920001223 polyethylene glycol Polymers 0.000 claims description 10
- 239000007762 w/o emulsion Substances 0.000 claims description 10
- 238000004132 cross linking Methods 0.000 claims description 8
- 239000002537 cosmetic Substances 0.000 claims description 7
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 4
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 4
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 claims description 3
- 229940008099 dimethicone Drugs 0.000 claims description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 claims description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 3
- 229920005650 polypropylene glycol diacrylate Polymers 0.000 claims description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 claims description 2
- OPDBGKQXNHUHTA-UHFFFAOYSA-O CC(=C)C(=O)P(=O)=C(O)C[N+](C)(C)C Chemical compound CC(=C)C(=O)P(=O)=C(O)C[N+](C)(C)C OPDBGKQXNHUHTA-UHFFFAOYSA-O 0.000 claims 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- 239000007764 o/w emulsion Substances 0.000 claims 1
- 239000000839 emulsion Substances 0.000 abstract description 27
- 238000009472 formulation Methods 0.000 description 25
- 239000003921 oil Substances 0.000 description 21
- 239000012071 phase Substances 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 12
- 241000282472 Canis lupus familiaris Species 0.000 description 11
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- 239000006185 dispersion Substances 0.000 description 7
- 238000001035 drying Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 5
- 239000004971 Cross linker Substances 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 229920000671 polyethylene glycol diacrylate Polymers 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000001000 micrograph Methods 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 125000004386 diacrylate group Chemical group 0.000 description 2
- 230000010102 embolization Effects 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 235000013382 Morus laevigata Nutrition 0.000 description 1
- 244000278455 Morus laevigata Species 0.000 description 1
- NWGKJDSIEKMTRX-BFWOXRRGSA-N [(2r)-2-[(3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-BFWOXRRGSA-N 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000005354 coacervation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000012674 dispersion polymerization Methods 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229940031709 peg-30-dipolyhydroxystearate Drugs 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000000164 protein isolation Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/025—Explicitly spheroidal or spherical shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/32—Polymerisation in water-in-oil emulsions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F230/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
- C08F230/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
- C08F290/02—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated end groups
- C08F290/06—Polymers provided for in subclass C08G
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2300/00—Characterised by the use of unspecified polymers
- C08J2300/14—Water soluble or water swellable polymers, e.g. aqueous gels
Definitions
- the present invention is a methacryloyl phosphoryl choline
- MPC relates to spherical hydrogel particles, and more particularly, to hydrogel particles made from an aqueous solution of a water-in-oil (w / o) emulsion dog using MPC and a water-soluble crosslinking agent and a method of preparing the same.
- hydrogel particles are made by chemical methods such as emulsified coacervation, physical methods of spray drying, and heterogeneous polymerization.
- emulsified coacervation emulsified coacervation
- physical methods of spray drying emulsified polymerization
- heterogeneous polymerization emulsified coacervation
- One example is the preparation of microcapsules with walls composed of polysaccharides through crosslinking reactions occurring at the interface using w / o emulsions (MC Levy et al., Int. J. Pharm., 62, 1990, 27-35; PCT / FR93 / 00237).
- the method uses a microcapsule having a size of several microns or more, in which only an interface portion is crosslinked through an interfacial crosslinking reaction resulting from an interface where an oil phase containing a crosslinking agent and a polysaccharide aqueous phase contact in a w / o emulsion. How to get.
- MPC hydrogels formed by these conventional methods are limited to bulky amorphous hydrogel forms, which are difficult to use for cosmetic applications.
- the present inventors proceeded a study to manufacture the MPC spherical hydrogel particles by chemically cross-linking the MPC present in the aqueous solution of w / o emulsion dog while adjusting a number of manufacturing parameters in order to solve the conventional problems. Specifically, all kinds of manufacturing parameters such as oil type, ratio of oil phase solution and water phase solution of w / o emulsion dog, type and concentration of surfactant were determined.
- an object of the present invention is to provide an MPC spherical hydrogel particle having an improved moisture feeling and easy to disperse on an emulsion dog, and a method for preparing the same.
- the present invention provides a hydrogel particles and a method for producing the same in the aqueous solution of w / o emulsion dog using MPC and a water-soluble crosslinking agent.
- the present invention relates to a hydrogel particle made from an aqueous solution of a w / o emulsion dog using MPC and a specific water-soluble crosslinking agent, and to a method for preparing the same. Since the particles of size and (30 ⁇ 50 ⁇ ⁇ ), the moisture is much improved than the conventional MPC hydrogel, it can be dispersed on the emulsion without the surfactant, it can be easily used in cosmetics. [Brief Description of Drawings]
- Figure 2 is a micrograph showing that the MPC spherical hydrogel according to the present invention is stably dispersed in both w / o, o / w formulation.
- Figure 3 is a micrograph showing the change in size before and after drying the MPC spherical hydrogel.
- Figure 4 is a graph showing the change in water change rate according to the addition of MPC spherical hydrogel according to the present invention to w / o.
- the present invention relates to spherical hydrogel particles made in an aqueous solution of a w / o emulsion using MPC and a specific water-soluble crosslinking agent and a method for preparing the same.
- the oil component used to prepare the MPC spherical hydrogel particles according to the present invention may be selected from one or more selected from the group consisting of vegetable, mineral, silicone and synthetic oils, preferably cetyl ethylnucleoanoate (Cetyl ethyl hexanoate, CEH), dodecane, heptane, and the like can be used.
- vegetable, mineral, silicone and synthetic oils preferably cetyl ethylnucleoanoate (Cetyl ethyl hexanoate, CEH), dodecane, heptane, and the like can be used.
- surfactant used to prepare the MPC spherical hydrogel particles according to the present invention at least one of surfactants capable of stabilizing w / o emulsions may be generally used, and preferably cetyl PEG / PPG. -10/1 dimethicone (Cetyl PEG / PPG-10 / 1 dimethi cone (ABIL EM-90)), sorbitan sesquioleate (ARLACEL 83), polyethylene glycol dipolyhydroxy stearate (Polyethylene glycol dipolyhydroxy stearate (ARLACEL P135)).
- the content of the surfactant is 1 to 10% by weight, preferably 2 to 6% by weight, based on the total weight of the mixture of the oil phase and the water phase of the w / o emulsion dog.
- the concentration of the surfactant is a factor that affects the size and stability of the w / o emulsion dog particles. If the concentration is less than 1 wt%, the size of the particles increases and the stability of the particles becomes unstable. Emulsion dog particles are stabilized, but since the surfactant becomes an impurity component that is not necessary in the finally obtained particles, there is a disadvantage in that the purity is lowered.
- the solvent used for preparing the aqueous phase solution is not particularly limited, but is preferably purified water.
- MPC Metaloyl phosphoryl cholene
- the water-soluble crosslinking agent used to prepare the MPC spherical hydrogel particles according to the present invention may be used by selecting one or more from crosslinking agents having the characteristic of forming crosslinking with the natural polymer polysaccharide.
- crosslinking agent bisepoxide is used as the crosslinking agent, an ether bond is formed instead of an ester bond, which is a crosslink, which is conventionally used through ester esters.
- PEG chain as a main chain of the crosslinking agent.
- Preference Polypropylene glycol diacrylate, PPG-DA or polyethylene glycol diacrylate (PEG-DA) is preferable, and polyethylene glycol diacrylate is more preferable.
- MPC spherical hydrogel particles crosslinked with the material show a fast and high degree of swelling in the water phase.
- the water-soluble crosslinking agent is used in an amount of 0.1 to 10% by weight based on the total weight of the mixture of the oil phase and the water phase.
- the MPC and the water-soluble crosslinking agent are preferably mixed in a weight ratio of 1: 9.
- Recovery of the MPC spherical hydrogel particles of e) is to wash the emulsion cross-linked emulsion with an organic solvent, to obtain the MPC spherical hydrogel particles in the aqueous phase solution, This is done by vacuum drying at 70 ⁇ 90 ° C to remove the residual organic solvent.
- the organic solvent is not limited as long as it is compatible with water, but is preferably selected from ethanol, methane, isopropyl alcohol, acetone and tetrahydrofuran.
- an aqueous solution containing dispersed MPC spherical hydrogel particles in order to completely remove impurities such as oils, surfactants, and anti-crosslinking agents that may be present in the MPC spherical hydrogel particles washed with an organic solvent. It may further comprise the step of washing it using an organic solvent.
- the MPC spherical hydrogel particles obtained through the preparation method described above can be used for the type and concentration of the crosslinking agent, the ratio of the aqueous solution of the w / o emulsion to the oil phase solution, the type of oil used in the w / o emulsion, and the surfactant.
- the particle size can range from tens to hundreds of nanometers in the dry state.
- MPC spherical hydrogel particles prepared according to the present invention can be stably dispersed in the emulsion composition such as oil, w / o or o / w without a surfactant, and thus can be efficiently used in the external composition of the skin such as cosmetic composition Can be.
- the emulsion composition such as oil, w / o or o / w without a surfactant
- the content may vary depending on the intended purpose and use, but may be preferably used in an amount of about 20% by weight based on the total weight of the composition.
- Hydrogels of Examples 1 and 2 and Comparative Example 1 were prepared in the compositions shown in Table 1 below (parts by weight). Specifically, Examples 1 and 2 are prepared in the aqueous solution of the w / o emulsion dog according to the present invention, Comparative Example 1 is a hydrogel prepared in the water phase.
- An oily solution was prepared by mixing PEG-30 dipolyhydroxy stearate as a surfactant in a nucleic acid.
- MPG and PEG-M or PPG-DA are mixed with purified water to prepare an aqueous solution.
- Hydrogelols of Formulation Examples 1 to 4 and Comparative Formulation Examples 1 and 2 were prepared in the compositions shown in Tables 2 and 3 below (weight%). Specifically, Formulation Examples 1 and 2 include the hydrogelols of Examples 1 and 2, respectively, as w / o formulations, and Formulation Examples 3 and 4 include the hydrogels of Examples 1 and 2, respectively, as o / w formulations. It is. Comparative Formulation Examples 1 and 2 are also compositions of w / o and o / w formulations comprising the hydrogelol of Comparative Example 1. [Table 2]
- the dispersion state of Formulation Examples 1 to 4, and Comparative Formulation Examples 1 and 3 in which the hydrogel particles according to the present invention were dispersed in a composition of the w / ⁇ or o / w formulation was measured, and Formulation Examples 1 and 3 The micrograph measured about is shown in FIG.
- Example 1 In the case of dispersing Example 1 or Example 2 on a single oil, in both cases the hydrogel particles were stably dispersed.
- Figure 1 showing the dispersion state of the hydrogel particles of Example 1, in the dispersion of MPC spherical hydrogel prepared according to the present invention in an oil phase solution, it was stably dispersed without a surfactant, but the same amount of water in the oil phase When added, it can be seen that separation occurs.
- the MPC hydrogel dispersion of Comparative Example 1 it can be confirmed that the dispersion does not occur without using a surfactant.
- the weight change before and after drying the hydrogel particles of Example 1 using a halogen humidity analyzer (Mett ler To ledo) after drying the MPC spherical hydrogel was measured at 5 minute intervals while heating at 105 ° C. for 60 minutes.
- the particle size change was observed in a microscope (Olympus, x200) and is shown in FIG. 3.
- the MPC spherical hydrogel particles remained 8.19 ⁇ 0.16% after drying, indicating that the weight change indicated that the MPC spherical hydrogel was bound with about 11.2 times moisture.
- looking at Figure 3 after drying the MPC spherical hydrogel it can be seen that the size is significantly smaller, which can be seen that the result of the decrease in the amount of water combined with the MPC spherical hydrogel throughout the drying process. .
- Formulation Example 1 and Comparative Formulation Example 2 were applied to the skin to measure the change in moisture content.
- moisture To measure the amount, 10 subjects 20 to 50 years of age were washed with both soaps with soap, and the skin was depressed for about 15 minutes under constant temperature and humidity conditions (20 ° C, RH 40%).
- the moisture content before application was measured using a moisture content measuring instrument (Corneometer ® CM825, C + K, Germany), and then in Formulation Example 1 on one forearm and Comparative Formulation Example 2 on the other forearm in an amount of 2 ⁇ 1 per 1 cm 2 .
- the amount of water was measured to calculate the increase and decrease is shown in Table 4,
- Formulation Example 1 containing the MPC spherical hydrogel prepared according to the present invention is compared to Comparative Formulation Example 2 containing no MPC spherical hydrogel, immediately after the application, 1 hour after application, the application 3 After 24 hours, the amount of water increased significantly (144.0%, 124.0%, 96.0).
- the MPC spherical hydrogel according to the present invention has a high water retention, and thus can realize high moisturizing power when applied to various formulations.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Colloid Chemistry (AREA)
Abstract
The present invention relates to spherical hydrogel particles of methacryloyl phosphoryl choline (MPC) and, more specifically, to hydrogel particles which are prepared in an aqueous solution of a water-in-oil (w/o) type emulsion using MPC and a water-soluble cross-linking agent, and to a method for preparing the same.
Description
【명세서】 【Specification】
[발명의 명칭】 [Name of invention]
MPC와 수용성 가교제를 이용한 구형 하이드로겔 입자 Spherical Hydrogel Particles Using MPC and Water-soluble Crosslinker
【기술분야】 Technical Field
<1> 본 발명은 메타크릴로일 포스포릴콜린 (Methacryloyl phosphor yl choline, <1> The present invention is a methacryloyl phosphoryl choline,
MPC) 구형 하이드로겔 입자에 관한 것으로, 더욱 상세하게는 MPC와 수용성 가교제 를 이용하여 유중수형 (w/o) 에멀견의 수상 용액에서 만들어진 하이드로겔 입자 및 이의 제조방법에 관한 것이다. MPC) relates to spherical hydrogel particles, and more particularly, to hydrogel particles made from an aqueous solution of a water-in-oil (w / o) emulsion dog using MPC and a water-soluble crosslinking agent and a method of preparing the same.
【배경기술】 Background Art
<2> 1980년대 후반에서 1990년대까지 하이드로겔 입자에 관한 연구는 고분자 재 료를 마이크로 크기로 입자화하고 표면 및 내부를 화학적으로 개질함으로써 색전술 (embolization), 효소고정화 (enzyme immobilization), 약물전달 (drug delivery) 등 의 분야에 웅용되어 왔다. 2000년대에 진입하면서는 나노기술의 발달과 더불어 수 용성 고분자를 이용한 나노크기의 입자 제조 및 웅용에 관한 연구가 진행되고 있 다. 현재까지 하이드로겔 입자에 관한 대부분의 연구는 바이오신약 및 바이오장기 분야에 웅용을 목적으로 하여 생분해성 고분자를 사용하며, 비침습적 (non¬ invasive) 시술을 위해 주입가능형 (injectable) 구조로 제조하는 것에 집중되고 있 다. 상기 분야는 약물전달시스템, 색전술ᅳ 조직공학용 스캐폴드, 벌킹 에이전트 (bulking agent) 및 임플란트 (implant) 둥을 포함한다. 이밖에 단백질의 분리, 농 축 및 안정화, 면역검정 (immunoassay), 바이오리액터 (bioreactor), 센서, 바이오스 페시픽 (biospecific) 크로마토그래피, 화장품 층진제 (cosmetic filler) 등의 분야 에도 폭넓게 사용되고 있다. 이러한 하이드로겔 입자는 에멀젼화 코아세르베이션, 분무 건조 둥의 물리적 방법 및 불균일계 중합과 같은 화학적 방법으로 만들어진 다. 그 한가지 예로 w/o 에멀견을 이용하여 계면에서 일어나는 가교반웅올 통하여 다당류로 구성된 벽을 가지는 마이크로캡슐의 제조를 들 수 있다 (M.C. Levy et al., Int. J. Pharm., 62, 1990, 27-35; PCT/FR93/00237) . 상기 방법은 w/o 에멀견 에서 가교제를 함유하는 오일상과 다당류를 함유하는 수상이 접촉하는 계면에서 발 생하는 계면가교 반웅올 통해서 계면부분만이 가교된, 수 마이크론 이상의 크기를 가지는 마이크로캡슐을 얻는 방법이다. <2> The study of hydrogel particles from the late 1980s to the 1990s involved embolization, enzyme immobilization, and drug delivery by granulating polymer materials into micro-sized particles and chemically modifying surfaces and interiors. drug delivery). Entering the 2000s, with the development of nanotechnology, research on the preparation and use of nano-sized particles using water-soluble polymers is in progress. To date, most studies on hydrogel particles use biodegradable polymers for their purpose in biopharmaceuticals and bio-organs, and are manufactured in an injectable structure for non ¬ invasive procedures. It is focused on things. The field includes drug delivery systems, embolization® tissue engineering scaffolds, bulking agents and implant donuts. It is also widely used in the fields of protein isolation, concentration and stabilization, immunoassays, bioreactors, sensors, biospecific chromatography, and cosmetic fillers. These hydrogel particles are made by chemical methods such as emulsified coacervation, physical methods of spray drying, and heterogeneous polymerization. One example is the preparation of microcapsules with walls composed of polysaccharides through crosslinking reactions occurring at the interface using w / o emulsions (MC Levy et al., Int. J. Pharm., 62, 1990, 27-35; PCT / FR93 / 00237). The method uses a microcapsule having a size of several microns or more, in which only an interface portion is crosslinked through an interfacial crosslinking reaction resulting from an interface where an oil phase containing a crosslinking agent and a polysaccharide aqueous phase contact in a w / o emulsion. How to get.
<3> 종래에는 카르보디이미드 가교제 (carbodiimide crosslinker )를 사용하여, <3> Conventionally, using a carbodiimide crosslinker (carbodiimide crosslinker),
MPC와 PEG-디아크릴레이트를 가교시키고, 하이드로겔을 제조할 수 있다고 밝혀졌으 나, 유중수 에멀젼의 수상 용액에서 하이드로겔을 제조하는 방법은 개시되지 않았
고 (국제특허공개 W02011/038485)ᅳ PEG-디아크릴레이트를 가교시킨 MPC를 이용한 고 분자 네트워크에 대하여 연구되었으나, 역시 w/o 에멀견의 수상 용액에서 하이드로 겔을 제조하는 방법은 개시되지 않았다 ( "Col l agen-phosphorylchol ine interpenetrat ing networkhydrogel s as corneal subst i tutes" , Wenguang Liu et al . , Biomater i al s 30 (2009) 1551-1559) . 이러한 종래 방법들에 의해 형성된 MPC 하이드로겔은 부피가 큰 무정형의 하이드로겔 형태에 한정되어 있어 화장품 용도로 사용하기 어렵다는 한계가 있었다. It has been found that crosslinking of MPC and PEG-diacrylate and hydrogels can be made, but a method for preparing hydrogels in an aqueous solution of a water-in-oil emulsion has not been disclosed. Although high molecular networks have been studied using MPC crosslinked with PEG-diacrylate, a method for preparing hydrogels in an aqueous solution of w / o emulsion dogs has not been disclosed (see, eg, W02011 / 038485). "Col agen-phosphorylchol ine interpenetrat ing network hydrogel s as corneal subst i tutes", Wenguang Liu et al., Biomater i al s 30 (2009) 1551-1559). MPC hydrogels formed by these conventional methods are limited to bulky amorphous hydrogel forms, which are difficult to use for cosmetic applications.
【발명의 상세한 설명】 [Detailed Description of the Invention]
【기술적 과제】 [Technical problem]
이에, 본 발명자들은 종래의 문제점을 해결하기 위하여 제조상의 여러 변수 들을 조절하면서 w/o 에멀견의 수상 용액에 존재하는 MPC를 화학적으로 가교시켜 MPC 구형 하이드로겔 입자를 제조하는 연구를 진행하였다. 구체적으로 오일의 종 류, w/o 에멀견의 오일상 용액과 수상 용액의 비율, 계면활성제의 종류 및 농도 등 올 제조상의 변수들로 정하였다. Thus, the present inventors proceeded a study to manufacture the MPC spherical hydrogel particles by chemically cross-linking the MPC present in the aqueous solution of w / o emulsion dog while adjusting a number of manufacturing parameters in order to solve the conventional problems. Specifically, all kinds of manufacturing parameters such as oil type, ratio of oil phase solution and water phase solution of w / o emulsion dog, type and concentration of surfactant were determined.
그 결과, MPC와 특정 수용성 가교제를 이용하여 구형으로 하이드로겔 입자를 제조하는 경우, 기존 제조 방법들에 의해 형성된 MPC 하이드로겔보다 수분감이 매 우 향상되고, 계면활성제 없이도 에멀견 상에 쉽게 분산이 가능함을 발견하고 본 발명을 완성하였다. As a result, when hydrogel particles are spherically prepared using MPC and a specific water-soluble crosslinking agent, moisture feeling is much improved than that of MPC hydrogel formed by conventional manufacturing methods, and it is easy to disperse on an emulsion without a surfactant. And the present invention was completed.
따라서, 본 발명은 향상된 수분감을 가지며, 에멀견 상에의 분산이 용이한 MPC 구형 하이드로겔 입자 및 이의 제조방법을 제공하는데 그 목적이 있다. Accordingly, an object of the present invention is to provide an MPC spherical hydrogel particle having an improved moisture feeling and easy to disperse on an emulsion dog, and a method for preparing the same.
【기술적 해결방법】 Technical Solution
상기와 같은 목적을 달성하기 위하여, 본 발명은 MPC와 수용성 가교제를 이 용하여 w/o 에멀견의 수상 용액에서 만들어진 하이드로겔 입자 및 이의 제조방법을 제공한다. In order to achieve the above object, the present invention provides a hydrogel particles and a method for producing the same in the aqueous solution of w / o emulsion dog using MPC and a water-soluble crosslinking agent.
【유리한 효과】 Advantageous Effects
본 발명은 MPC와 특정 수용성 가교제를 이용하여 w/o 에멀견의 수상 용액에 서 만들어진 하이드로겔 입자 및 이의 제조방법에 관한 것으로 제조된 MPC 구형 하이드로겔은 크기가 작은 구형의 젤 입자 형태로 동일한 형태와 크기의 입자가 형 성되기 때문에 (30~50 μ ηι) , 기존의 MPC 하이드로겔보다 수분감이 매우 향상되며, 계 면활성제 없이 에멀견 상에 분산이 가능하여, 화장품 등에 쉽게 이용될 수 있다. 【도면의 간단한 설명】 The present invention relates to a hydrogel particle made from an aqueous solution of a w / o emulsion dog using MPC and a specific water-soluble crosslinking agent, and to a method for preparing the same. Since the particles of size and (30 ~ 50 μ ηι), the moisture is much improved than the conventional MPC hydrogel, it can be dispersed on the emulsion without the surfactant, it can be easily used in cosmetics. [Brief Description of Drawings]
도 1은 본 발명에 따른 MPC 구형 하이드로겔을 오일상 용액에 분산시켰을때,
계면활성제 없이 안정하게 분산됨을 나타낸 사진이다. 1 is when the MPC spherical hydrogel according to the present invention is dispersed in an oily solution, It is a photograph showing that it is stably dispersed without a surfactant.
도 2는 본 발명에 따른 MPC 구형 하이드로겔이 w/o , o/w 제형에 모두 안정하 게 분산됨을 나타낸 현미경 사진이다. Figure 2 is a micrograph showing that the MPC spherical hydrogel according to the present invention is stably dispersed in both w / o, o / w formulation.
도 3은 MPC 구형 하이드로겔의 건조 전과 건조 후의 크기 변화를 나타낸 현 미경 사진이다. Figure 3 is a micrograph showing the change in size before and after drying the MPC spherical hydrogel.
도 4는 w/o에 본 발명에 따른 MPC 구형 하이드로겔 첨가에 따른 수분 증감율 변화를 나타낸 그래프이다. Figure 4 is a graph showing the change in water change rate according to the addition of MPC spherical hydrogel according to the present invention to w / o.
【발명의 실시를 위한 최선의 형태】 [Best form for implementation of the invention]
본 발명은 MPC와 특정 수용성 가교제를 이용하여 w/o 에멀젼의 수상 용액에 서 만들어진 구형 하이드로겔 입자 및 이의 제조방법에 관한 것이다. The present invention relates to spherical hydrogel particles made in an aqueous solution of a w / o emulsion using MPC and a specific water-soluble crosslinking agent and a method for preparing the same.
이하, 본 발명을 보다 구체적으로 설명한다. Hereinafter, the present invention will be described in more detail.
본 발명에 따른 MPC와 수용성 가교제를 이용한 구형 하이드로겔 입자를 제조 하는 방법은 Method for producing spherical hydrogel particles using MPC and a water-soluble crosslinking agent according to the present invention
a) 오일성분에 계면활성제를 용해시켜 오일상 용액을 제조하는 단계; a) dissolving a surfactant in an oil component to prepare an oil phase solution;
b) MPC 및 수용성 가교제를 용매에 용해시켜 수상 용액을 제조하는 단계; c) 상기 a)의 용액에 상기 b)의 용액을 투입하여 w/o 에멀견을 형성하는 단 계; b) dissolving the MPC and the water soluble crosslinker in a solvent to prepare an aqueous solution; c) injecting the solution of b) into the solution of a) to form a w / o emulsion;
d) 상기 c)의 w/o 에멀젼을 40~150°C로 가열하면서 수상 용액 상의 가교제와 MPC와의 가교반웅을 진행시키는 단계 ; 및 d) advancing the crosslinking reaction of the crosslinking agent on the aqueous solution with MPC while heating the w / o emulsion of c) to 40 ° C. to 150 ° C .; And
e) 상기 d)의 w/o 에멀젼으로부터 MPC 구형 하이드로겔 입자를 회수하는 단 계를 포함하는 것을 특징으로 한다. e) recovering MPC spherical hydrogel particles from the w / o emulsion of d).
본 발명에 따른 MPC 구형 하이드로겔 입자를 제조하는데 사용되는 상기 오일 성분으로는 식물성, 광물성, 실리콘유 및 합성유로 이루어진 군으로부터 1종 이상 선택하여 사용할 수 있으며, 바람직하게는 세틸 에틸핵사노에이트 (Cetyl ethyl hexanoate , CEH) , 도데칸 (Dodecane), 헵탄 (Heptane) 등을 사용할 수 있다. The oil component used to prepare the MPC spherical hydrogel particles according to the present invention may be selected from one or more selected from the group consisting of vegetable, mineral, silicone and synthetic oils, preferably cetyl ethylnucleoanoate (Cetyl ethyl hexanoate, CEH), dodecane, heptane, and the like can be used.
본 발명에 따른 MPC 구형 하이드로겔 입자를 제조하는데 사용되는 상기 계면 활성제로는 일반적으로 w/o 에멀젼을 안정화시킬 수 있는 계면활성제들 중에서 1종 이상 선택하여 사용할 수 있으며, 바람직하게는 세틸 PEG/PPG-10/1 디메치콘 (Cetyl PEG/PPG- 10/1 dimethi cone (ABIL EM-90) ) , 소르비탄 세스퀴올레이트 (Sorbi tan sesquioleate (ARLACEL 83) ), 폴리에틸렌 글리콜 디폴리하이드록시 스테아레이트 (Polyethylene glycol dipolyhydroxy stearate (ARLACEL P135) )등을 사용할 수 있 다.
본 발명에서 상기 계면활성제의 함량은 w/o 에멀견의 오일상과 수상의 흔합 액 총 중량에 대하여 1~10중량 %이며, 바람직하게는 2~6중량 )이다. 상기 계면활성제 의 농도는 w/o 에멀견 입자의 크기와 안정도에 영향을 주는 요인으로, 1중량 % 미만 이면 입자들의 크기가 증가하고 입자의 안정도가 불안정해지며, 10중량 % 초과이면 w/o 에멀견 입자는 안정화되지만, 최종적으로 얻어지는 입자에서 계면활성제는 필 요없는 불순물 성분이 되므로 순도가 낮아지는 단점이 있다. As the surfactant used to prepare the MPC spherical hydrogel particles according to the present invention, at least one of surfactants capable of stabilizing w / o emulsions may be generally used, and preferably cetyl PEG / PPG. -10/1 dimethicone (Cetyl PEG / PPG-10 / 1 dimethi cone (ABIL EM-90)), sorbitan sesquioleate (ARLACEL 83), polyethylene glycol dipolyhydroxy stearate (Polyethylene glycol dipolyhydroxy stearate (ARLACEL P135)). In the present invention, the content of the surfactant is 1 to 10% by weight, preferably 2 to 6% by weight, based on the total weight of the mixture of the oil phase and the water phase of the w / o emulsion dog. The concentration of the surfactant is a factor that affects the size and stability of the w / o emulsion dog particles. If the concentration is less than 1 wt%, the size of the particles increases and the stability of the particles becomes unstable. Emulsion dog particles are stabilized, but since the surfactant becomes an impurity component that is not necessary in the finally obtained particles, there is a disadvantage in that the purity is lowered.
본 발명에 따른 MPC 구형 하이드로겔 입자를 제조하는데 있어서, 수상 용액 의 제조에 사용되는 용매는 특별히 한정되는 것은 아니지만, 바람직하게는 정제수 이다. In preparing the MPC spherical hydrogel particles according to the present invention, the solvent used for preparing the aqueous phase solution is not particularly limited, but is preferably purified water.
본 발명에 있어서, MPC(Methacryloyl phosphoryl chol ine)는 오일상과 수상 의 흔합액 총 중량에 대하여 0.1~20 중량 ¾)의 양으로 사용된다. In the present invention, MPC (Methacryloyl phosphoryl cholene) is used in an amount of 0.1 to 20 weight ¾) based on the total weight of the oil and water mixtures.
본 발명에 따른 MPC 구형 하이드로겔 입자를 제조하는데 사용되는 상기 수용 성 가교제로는 천연고분자 다당류와 가교결합을 형성하는 특징을 가지는 가교제들 로부터 1종 이상 선택하여 사용할 수 있다. 상기 가교제로서 비스에폭시드를 사용 하면 기존에 에스터화반웅 (esterf kat ion)을 통해 많이 사용되던 가교결합인 에스 터 (ester )결합이 아닌 에테르 (ether)결합을 형성하게 된다. 또한 가교된 구조가 물 에 분산되었을 경우 가교구조를 이루는 성분들이 물과 좀 더 친한 성격을 가지게 하기 위하여 PEG 체인 (chain)을 가교제의 주쇄로 사용하는 것을 고려하예 본 발명 에서는 특히 폴리프로필렌 글리콜 디아크릴레이트 (Polypropylene glycol diacrylate , PPG— DA) 또는 폴리에틸렌 글리콜 디아크릴레이트 (Polyethylene glycol di aery l ate , PEG-DA)가 바람직하며, 폴리에틸렌 글리콜 디아크릴레이트를 사용하는 것이 보다 바람직하다. 상기 물질로 가교된 MPC 구형 하이드로겔 입자는 수상에서 빠르고 높은 팽윤도를 보인다. The water-soluble crosslinking agent used to prepare the MPC spherical hydrogel particles according to the present invention may be used by selecting one or more from crosslinking agents having the characteristic of forming crosslinking with the natural polymer polysaccharide. When bisepoxide is used as the crosslinking agent, an ether bond is formed instead of an ester bond, which is a crosslink, which is conventionally used through ester esters. In addition, when the crosslinked structure is dispersed in water, in order to make the components forming the crosslinked structure more familiar with water, it is considered to use PEG chain as a main chain of the crosslinking agent. Preference (Polypropylene glycol diacrylate, PPG-DA) or polyethylene glycol diacrylate (PEG-DA) is preferable, and polyethylene glycol diacrylate is more preferable. MPC spherical hydrogel particles crosslinked with the material show a fast and high degree of swelling in the water phase.
본 발명에서 상기 수용성 가교제는 오일상과 수상의 흔합액 총 중량에 대하 여 0.1~10중량 >의 양으로 사용된다. In the present invention, the water-soluble crosslinking agent is used in an amount of 0.1 to 10% by weight based on the total weight of the mixture of the oil phase and the water phase.
또한, 본 발명에서 상기 MPC와 수용성 가교제는 1 :9의 중량 비율로 흔합되는 것이 바람직하다. In the present invention, the MPC and the water-soluble crosslinking agent are preferably mixed in a weight ratio of 1: 9.
본 발명에 있어서, w/o 에멀젼을 구성하는데 사용되는 계면활성제가 용해된 오일상 용액 및 MPC 및 수용성 가교제가 용해된 수상 용액의 흔합비율은 중량기준 으로 오일상 용액 : 수상 용액 = 1: 1~7:3인 것이 바람직하다. In the present invention, the mixing ratio of the oil phase solution in which the surfactant used to constitute the w / o emulsion and the aqueous phase solution in which the MPC and the water-soluble crosslinking agent are dissolved is based on the weight of the oil phase solution: aqueous solution = 1: 1 to 1 ~. 7: 3 is preferred.
상기 e)의 MPC 구형 하이드로겔 입자의 회수는 가교반응이 완료된 에멀견을 유기용매로 세척한 다음, 수상 용액 상의 MPC 구형 하이드로겔 입자를 취득하고,
이를 70~90 °C에서 진공 건조하여 잔류 유기용매를 제거하는 단계로 이루어진다. 상기 유기용매는 물에 흔합 가능한 것이면 제한되지 않지만, 에탄올, 메탄 을, 아이소프로필알코올, 아세톤, 테트라하이드로퓨란으로부터 선택되는 것이 바람 직하다. Recovery of the MPC spherical hydrogel particles of e) is to wash the emulsion cross-linked emulsion with an organic solvent, to obtain the MPC spherical hydrogel particles in the aqueous phase solution, This is done by vacuum drying at 70 ~ 90 ° C to remove the residual organic solvent. The organic solvent is not limited as long as it is compatible with water, but is preferably selected from ethanol, methane, isopropyl alcohol, acetone and tetrahydrofuran.
선택적으로, 유기용매를 이용하여 세척된 MPC 구형 하이드로겔 입자들에 존 재할 수 있는 오일, 계면활성제, 미반웅 가교제 등의 불순물을 완벽하게 제거하기 위하여, 세척된 MPC 구형 하이드로겔 입자가 분산된 수용액을 만들고, 이를 유기용 매를 이용하여 세척하는 단계가 더 포함될 수 있다. Optionally, an aqueous solution containing dispersed MPC spherical hydrogel particles in order to completely remove impurities such as oils, surfactants, and anti-crosslinking agents that may be present in the MPC spherical hydrogel particles washed with an organic solvent. It may further comprise the step of washing it using an organic solvent.
상기의 제조방법올 통해 얻어지는 MPC 구형 하이드로겔 입자는 가교제의 종 류 및 농도, w/o 에멀젼의 수상 용액과 오일상 용액의 비율, w/o 에멀견에 사용되 는 오일의 종류, 계면활성제의 종류 및 농도 둥의 제조상의 변수들을 조절함에 따 라 건조한 상태에서 수십에서 수백 나노미터의 입자크기를 가질 수 있다. The MPC spherical hydrogel particles obtained through the preparation method described above can be used for the type and concentration of the crosslinking agent, the ratio of the aqueous solution of the w / o emulsion to the oil phase solution, the type of oil used in the w / o emulsion, and the surfactant. By controlling the manufacturing parameters of the type and concentration, the particle size can range from tens to hundreds of nanometers in the dry state.
본 발명에 따라 제조되는 MPC 구형 하이드로겔 입자는 오일, w/o 또는 o/w 등의 유화 조성물에 계면활성제 없이도 안정적으로 분산될 수 있으며, 따라서 화장 료 조성물 등의 피부 외용제 조성물에서 효율적으로 활용될 수 있다. MPC spherical hydrogel particles prepared according to the present invention can be stably dispersed in the emulsion composition such as oil, w / o or o / w without a surfactant, and thus can be efficiently used in the external composition of the skin such as cosmetic composition Can be.
본 발명의 MPC 구형 하이드로겔 입자가 피부 외용제 조성물에서 사용될 경 우, 의도하는 목적 및 용도에 따라서 함량이 달라질 수 있으나, 바람직하게는 조성 물 총 중량에 대하여 대략 20 중량 %의 양으로 사용될 수 있다. When the MPC spherical hydrogel particles of the present invention are used in the external preparation composition for skin, the content may vary depending on the intended purpose and use, but may be preferably used in an amount of about 20% by weight based on the total weight of the composition.
【발명의 실시를 위한 형태】 [Form for implementation of invention]
본 발명은 하기 실시예 및 시험예에 의하여 더욱 구체적으로 설명한다. 그러 나, 하기 실시예 및 시험예는 본 발명에 대한 이해를 돕기 위한 것일 뿐, 어떤 의 미로든 본 발명의 범위가 이러한 실시예 및 시험예에 의하여 한정되는 것은 아니 다. The present invention will be described in more detail by the following examples and test examples. However, the following examples and test examples are only to help the understanding of the present invention, the scope of the present invention in any sense is not limited by these examples and test examples.
[참고예 1] MPC 하이드로겔의 제조 Reference Example 1 Preparation of MPC Hydrogel
하기 표 1에 기재된 조성으로 실시예 1~2 및 비교예 1의 하이드로겔을 제조 하였다 (중량부) . 구체적으로, 실시예 1~2는 본 발명에 따라서 w/o 에멀견의 수상 용액에서 제조한 것이고, 비교예 1은 수상에서 제조한 하이드로겔이다. Hydrogels of Examples 1 and 2 and Comparative Example 1 were prepared in the compositions shown in Table 1 below (parts by weight). Specifically, Examples 1 and 2 are prepared in the aqueous solution of the w / o emulsion dog according to the present invention, Comparative Example 1 is a hydrogel prepared in the water phase.
【표 1】
Table 1
<제조방법 - 실시예 1 및 2> <Manufacturing Method-Examples 1 and 2>
1) 핵산에 계면활성제인 PEG-30 디폴리하이드록시 스테아레이트를 흔합하여 오일상 용액을 제조하였다. 1) An oily solution was prepared by mixing PEG-30 dipolyhydroxy stearate as a surfactant in a nucleic acid.
2) 정제수에 MPG, 및 PEG-M 또는 PPG-DA를 흔합하여 수상 용액을 제조한다. 2) MPG and PEG-M or PPG-DA are mixed with purified water to prepare an aqueous solution.
3) 1)의 용액에 2)의 용액을 천천히 첨가하면서 유화기로 1800~2000rpm의 속 도로 10분간 흔합 교반시켜 에멀견올 제조한다. 3) While slowly adding the solution of 2) to the solution of 1), the mixture is stirred for 10 minutes at a speed of 1800 to 2000 rpm with an emulsifier to prepare an emulsion.
4) 에멀젼이 유지되도톡 1800~2000rpm으로 교반하면서 70°C에서 가열하여 가 교 반옹을 진행한다. 4) Heat the mixture at 70 ° C while stirring at 1800 ~ 2000rpm to maintain the emulsion.
5) 반웅을 마친 에멀견을 아이소프로필알코올에 침전을 시키고 침전된 MPC 구형 하이드로겔 입자를 분리한다. 5) After the reaction, precipitate the emulsion in isopropyl alcohol and separate the precipitated MPC spherical hydrogel particles.
6) 5)의 분리한 MPC 구형 하이드로겔 입자가 분산된 수용액을 만들어 다시 아이소프로필알코올에 침전시켜 잔존하는 오일, 계면활성제, 미반웅 가교제 등의 불순물을 제거한다. 6) Make an aqueous solution in which the separated MPC spherical hydrogel particles of 5) are dispersed and precipitate it again in isopropyl alcohol to remove impurities such as oil, surfactant, and unbound crosslinking agent.
7) 얻은 MPC 구형 하이드로겔 입자들을 70~90°C에서 24시간 동안 진공건조를 시켜 잔류 용매를 완벽하게 제거한다. 7) The obtained MPC spherical hydrogel particles are vacuum dried at 70-90 ° C. for 24 hours to completely remove residual solvent.
<제조방법 - 비교예 1> <Manufacturing Method-Comparative Example 1>
MPC와 PEG-DA를 물에 용해 시킨후 70°C에서 가온 반웅시킨다. [참조예 2] MPC 하이드로겔을 포함하는 조성물의 제조 MPC and PEG-DA are dissolved in water and warmed at 70 ° C. Reference Example 2 Preparation of Composition Containing MPC Hydrogel
하기 표 2 및 3에 기재된 조성으로 제형예 1 내지 4, 비교제형예 1 및 2의 하이드로겔올 제조하였다 (중량 %) . 구체적으로 제형예 1 및 2는 w/o 제형으로서 각 각 실시예 1 및 2의 하이드로겔올 포함하는 것이고, 제형예 3 및 4는 o/w 제형으로 서 각각 실시예 1 및 2의 하이드로겔을 포함하는 것이다. 또한, 비교제형예 1 및 2 는 비교예 1의 하이드로겔올 포함하는 w/o 및 o/w 제형의 조성물이다.
【표 2] Hydrogelols of Formulation Examples 1 to 4 and Comparative Formulation Examples 1 and 2 were prepared in the compositions shown in Tables 2 and 3 below (weight%). Specifically, Formulation Examples 1 and 2 include the hydrogelols of Examples 1 and 2, respectively, as w / o formulations, and Formulation Examples 3 and 4 include the hydrogels of Examples 1 and 2, respectively, as o / w formulations. It is. Comparative Formulation Examples 1 and 2 are also compositions of w / o and o / w formulations comprising the hydrogelol of Comparative Example 1. [Table 2]
w/o 제형 w / o formulation
【표 3】 Table 3
o/w 제형 o / w formulation
[시험예 1] MPC 구형 하이드로겔의 특성 Test Example 1 Characteristics of MPC Spherical Hydrogel
단일 오일상 (하이드로제네이티드 폴리데센 이용)에 실시예 1~2 또는 비교예
1의 MPC 하이드로겔, 또는 하이드로겔과 동량의 물을 분산시킨 다음 분산 상태를 관찰하였으며, 실시예 1에 대하여 측정한 현미경 사진 및 비교예 1에 대하여 육안 으로 관찰한 사진을 도 1에 나타내었다. 또한, w/ο ·또는 o/w 제형의 조성물에 본 발명에 따른 하이드로겔 입자를 분산시킨 상기 제형예 1~4, 및 비교제형예 1 및 3 의 분산 상태를 측정하였으며, 제형예 1 및 3에 대하여 측정한 현미경 사진을 도 2 에 나타내었다. Examples 1-2 or comparative examples in a single oil phase (using hydrogenated polydecene) 1 MPC hydrogel, or the same amount of water and the hydrogel was dispersed and the dispersion state was observed, and the microscopic picture measured for Example 1 and the visual observation for Comparative Example 1 are shown in FIG. In addition, the dispersion state of Formulation Examples 1 to 4, and Comparative Formulation Examples 1 and 3 in which the hydrogel particles according to the present invention were dispersed in a composition of the w / ο or o / w formulation was measured, and Formulation Examples 1 and 3 The micrograph measured about is shown in FIG.
단일 오일상에 실시예 1 또는 실시예 2를 분산시킨 경우에는 2가지 경우 모 두 하이드로겔 입자가 안정적으로 분산하였다. 특히 실시예 1의 하이드로겔 입자의 분산 상태를 나타낸 도 1을 살펴보면, 오일상 용액에 본 발명에 따라 제조한 MPC 구형 하이드로겔 분산시에는 계면활성제 없이 안정하게 분산되었으나 오일상에 같 은 양의 물을 첨가한 경우는 분리가 일어남을 확인할 수 있다. 또한, 비교예 1의 MPC 하이드로겔 분산시에는 계면활성제를 사용하지 않으면 분산이 되지 않는다는 것을 확인할 수 있다. In the case of dispersing Example 1 or Example 2 on a single oil, in both cases the hydrogel particles were stably dispersed. In particular, referring to Figure 1 showing the dispersion state of the hydrogel particles of Example 1, in the dispersion of MPC spherical hydrogel prepared according to the present invention in an oil phase solution, it was stably dispersed without a surfactant, but the same amount of water in the oil phase When added, it can be seen that separation occurs. In addition, when the MPC hydrogel dispersion of Comparative Example 1, it can be confirmed that the dispersion does not occur without using a surfactant.
또한, 도 2을 살펴보면, 본 발명에 따라 제조한 MPC 구형 하이드로겔 입자를 분산시킨 제형은 w/o 제형이든 o/w 제형이든 계면활성제를 사용하지 않고서도 분리 가 일어나지 않은 상태로 모두 안정하게 분산되었음을 확인할 수 있다. In addition, referring to Figure 2, the formulation of the dispersion of the MPC spherical hydrogel particles prepared according to the present invention, both w / o formulations or o / w formulations are all dispersed in a stable state without separation without using a surfactant It can be confirmed.
[시험예 2] MPC 구형 하이드로겔의 수분량 측정 Test Example 2 Measurement of Water Content of MPC Spherical Hydrogel
본 발명에 따른 MPC 구형 하이드로겔 입자의 수분량올 측정하기 위하여 , MPC 구형 하이드로겔을 건조시킨 후 할로겐 습도 분석기 (Mett ler To ledo)를 이용하여 상기 실시예 1의 하이드로겔 입자의 건조 전후의 무게변화를 105 °C에서 60분 동안 가열하면서 5분 간격으로 측정하였다. 입자의 크기 변화를 현미경 (Olympus , x200) 으로 관찰하여 도 3에 나타내었다. In order to measure the moisture content of the MPC spherical hydrogel particles according to the present invention, the weight change before and after drying the hydrogel particles of Example 1 using a halogen humidity analyzer (Mett ler To ledo) after drying the MPC spherical hydrogel Was measured at 5 minute intervals while heating at 105 ° C. for 60 minutes. The particle size change was observed in a microscope (Olympus, x200) and is shown in FIG. 3.
MPC 구형 하이드로겔 입자는 건조 후, 8. 19± 0. 16% 잔존하였으며, 이 무게 변화는 MPC 구형 하이드로겔이 약 11.2배의 수분과 결합했다는 것을 나타낸다. 또 한, 도 3을 살펴보면, MPC 구형 하이드로겔의 건조 후에는 크기가 현저하게 작아짐 을 확인할 수 있는데, 이는 건조과정올 거치면서 MPC 구형 하이드로겔과 결합된 수 분량의 감소에 따른 결과임을 알 수 있다. The MPC spherical hydrogel particles remained 8.19 ± 0.16% after drying, indicating that the weight change indicated that the MPC spherical hydrogel was bound with about 11.2 times moisture. In addition, looking at Figure 3, after drying the MPC spherical hydrogel it can be seen that the size is significantly smaller, which can be seen that the result of the decrease in the amount of water combined with the MPC spherical hydrogel throughout the drying process. .
[시험예 3] MPC 구형 하이드로겔의 보습력 측정 Test Example 3 Measurement of Moisturizing Power of MPC Spherical Hydrogel
본 발명에 따른 MPC 구형 하이드로겔 입자의 보습력을 측정하기 위하여, 상 기 제형예 1 및 비교제형예 2를 피부에 도포하여 수분량 변화를 측정하였다. 수분
량 측정을 위하여, 20~50세 연령의 피험자 10명을 대상으로 양쪽 전박을 비누로 깨 끗이 씻은 후, 항온항습조건 (20 °C , RH 40%)에서 약 15분 동안 피부를 적웅시켰다. 수분량 측정 기기 (Corneometer ®CM825 , C+K , 독일)를 이용하여 도포 전의 수분량을 측정하고, 이후 1cm2당 2 μ 1의 양으로 한쪽 전박에는 제형예 1을, 다른쪽 전박에는 비교제형예 2를 고르게 도포 시킨 후, 도포 직후, 1시간 후, 3시간 후의 수분량을 측정하여 증감율을 계산하여 표 4에 나타내었다, In order to measure the moisturizing power of the MPC spherical hydrogel particles according to the present invention, Formulation Example 1 and Comparative Formulation Example 2 were applied to the skin to measure the change in moisture content. moisture To measure the amount, 10 subjects 20 to 50 years of age were washed with both soaps with soap, and the skin was depressed for about 15 minutes under constant temperature and humidity conditions (20 ° C, RH 40%). The moisture content before application was measured using a moisture content measuring instrument (Corneometer ® CM825, C + K, Germany), and then in Formulation Example 1 on one forearm and Comparative Formulation Example 2 on the other forearm in an amount of 2 μ1 per 1 cm 2 . After applying evenly, after the application, after 1 hour, after 3 hours the amount of water was measured to calculate the increase and decrease is shown in Table 4,
상기 표 4에서 알 수 있듯이, 본 발명에 따라 제조된 MPC 구형 하이드로겔을 함유한 제형예 1은 MPC 구형 하이드로겔을 함유하지 않은 비교제형예 2에 비하여, 도포 직후, 도포 1시간 후, 도포 3시간 후에 각각 144.0%, 124.0%, 96.0 )의 수치로 수분량이 유의하게 증가하였다. 이는 본 발명에 따른 MPC 구형 하이드로겔은 높은 수분 보유력을 가지며, 이로 인해 다양한 제형에 적용할 경우에 높은 보습력을 구 현할 수 있음을 의미한다.
As can be seen in Table 4, Formulation Example 1 containing the MPC spherical hydrogel prepared according to the present invention is compared to Comparative Formulation Example 2 containing no MPC spherical hydrogel, immediately after the application, 1 hour after application, the application 3 After 24 hours, the amount of water increased significantly (144.0%, 124.0%, 96.0). This means that the MPC spherical hydrogel according to the present invention has a high water retention, and thus can realize high moisturizing power when applied to various formulations.
Claims
【청구항 1】 【Claim 1】
i ) 오일성분에 계면활성제를 용해시킨 오일상 용액; 및 i i ) 메타크릴로일 포 스포릴콜린 (Methacryloyl phosphoryl chol ine, MPC)과 수용성 가교제를 용해시킨 수상 용액이 흔합된 w/o 에멀젼에서 가교된, MPC 구형 하이드로겔 입자. i) An oil-like solution in which a surfactant is dissolved in an oil component; and i i) MPC spherical hydrogel particles crosslinked in a w/o emulsion mixed with an aqueous solution in which methacryloyl phosphoryl choline (MPC) and a water-soluble crosslinking agent are mixed.
【청구항 2】 【Claim 2】
저 U항에 있어서, 상기 계면활성제가 용해된 오일상 용액 및 메타크릴로일 포 스포릴콜린 (MPC)과 수용성 가교제가 용해된 수상 용액의 흔합비율은 중량기준으로 오일상 용액 : 수상 용액 = 1 : 1~7 :3인 것을 특징으로 하는 MPC 구형 하이드로겔 입 자. In item U, the mixing ratio of the oil-phase solution in which the surfactant is dissolved and the aqueous solution in which methacryloyl phosphorylcholine (MPC) and the water-soluble cross-linking agent are dissolved is, based on weight, oil phase solution: aqueous solution = 1 : MPC spherical hydrogel particles characterized in that the ratio is 1~7:3.
【청구항 3】 【Claim 3】
제 1항에 있어세 상기 오일성분은 세틸 에틸핵사노에이트 (Cetyl ethylhexanoate , CEH) , 도데칸 (Dodecane) 및 헵탄 (Heptane)으로 이루어진 군으로부 터 선택된 1종 이상임을 특징으로 하는 MPC 구형 하이드로겔 입자. The MPC spherical hydrogel according to claim 1, wherein the oil component is at least one selected from the group consisting of cetyl ethylhexanoate (CEH), dodecane, and heptane. particle.
【청구항 4] [Claim 4]
제 1항에 있어서, 상기 계면활성제는 세틸 PEG/PPG-10/1 디메치콘 (Cetyl PEG/PPG- 10/1 dimethi cone) , 소르비탄 세스퀴올레이트 (Sorbi tan sesquioleate) 및 폴리에틸렌 글리콜 디폴리하이드록시 스테아레이트 (Polyethylene glycol dipolyhydroxy stearate)로 이루어진 군으로부터 선택된 1종 이상임을 특징으로 하 는 MPC 구형 하이드로겔 입자. The method of claim 1, wherein the surfactant is cetyl PEG/PPG-10/1 dimethicone, sorbitan sesquioleate, and polyethylene glycol dipolyhydroxy. MPC spherical hydrogel particles characterized by containing at least one type selected from the group consisting of stearate (polyethylene glycol dipolyhydroxy stearate).
【청구항 5] [Claim 5]
제 1항에 있어서, 상기 계면활성제의 함량은 w/o 에멀젼의 오일상 용액과 수 상 용액의 흔합액 총 중량에 대하여 1~10중량 y。인 것을 특징으로 하는 MPC 구형 하 이드로겔 입자. The MPC spherical hydrogel particle according to claim 1, wherein the content of the surfactant is 1 to 10 weight y. based on the total weight of the mixture of the oil phase solution and the water phase solution of the w/o emulsion.
【청구항 6】 【Claim 6】
제 1항에 있어서, 상기 MPC의 함량은 오일상과 수상의 흔합액 총 중량에 대하 여 0.1-20중량 %인 것을 특징으로 하는 MPC구형 하이드로겔 입자. The MPC spherical hydrogel particle according to claim 1, wherein the content of the MPC is 0.1-20% by weight based on the total weight of the mixture of the oil phase and the water phase.
【청구항 7] [Claim 7]
제 1항에 있어서, 상기 수용성 가교제는 폴리프로필렌 글리콜 디아크릴레이트 및 폴리에틸¾ 글리콜 디아크릴레이트로 이루어진 군으로부터 선택된 1종 이상임을 특징으로 하는 MPC 구형 하이드로겔 입자. The MPC spherical hydrogel particle according to claim 1, wherein the water-soluble crosslinking agent is at least one selected from the group consisting of polypropylene glycol diacrylate and polyethyl¾ glycol diacrylate.
【청구항 8】
제 1항에 있어서, 상기 수용성 가교제의 함량은 오일상과 수상의 흔합액 총 중량에 대하여 0. 1~10중량 %인 것을 특징으로 하는 MPC 구형 하이드로겔 입자. 【Claim 8】 The MPC spherical hydrogel particle according to claim 1, wherein the content of the water-soluble crosslinking agent is 0.1 to 10% by weight based on the total weight of the mixture of the oil phase and the water phase.
【청구항 9] [Claim 9]
제 1항에 있어서, 상기 입자는 크기가 30~50 μ πι임을 특징으로 하는 MPC 구형 하이드로겔 입자. The MPC spherical hydrogel particle of claim 1, wherein the particle has a size of 30 to 50 μ πι.
【청구항 10] [Claim 10]
i ) 오일성분에 계면활성제를 용해시킨 오일상 용액 및 Π ) 메타크릴로일 포 스포릴콜린 (Methacryloyl phosphoryl chol ine , MPC)과 수용성 가교제를 용해시킨 수상 용액을 흔합하여 얻은 w/o 에멀견에서 가교시키는 단계를 포함하는, MPC 구형 하이드로겔 입자의 제조방법. i) w/o emulsion obtained by mixing an oil phase solution in which a surfactant is dissolved in an oil component and Π) an aqueous solution in which methacryloyl phosphoryl chol ine (MPC) and a water-soluble cross-linking agent are dissolved. Method for producing MPC spherical hydrogel particles, comprising the step of crosslinking.
【청구항 11】 【Claim 11】
제 10항에 있어서, 상기 MPC 구형 하이드로겔 입자의 제조방법은 하기의 단계 를 거쳐 제조되는 것을 특징으로 하는 MPC 구형 하이드로겔 입자의 제조방법: The method of claim 10, wherein the MPC spherical hydrogel particles are produced through the following steps:
a) 오일성분에 계면활성제를 용해시킨 오일상 용액을 제조하는 단계; a) preparing an oil-like solution in which a surfactant is dissolved in an oil component;
b) MPC 및 수용성 가교제를 용해시킨 수상 용액을 제조하는 단계; b) preparing an aqueous solution in which MPC and a water-soluble crosslinking agent are dissolved;
c) 상기 a)의 용액에 상기 b)의 용액을 투입하여 w/o 에멀견을 형성하는 단 계; c) adding the solution of b) to the solution of a) to form w/o emulsion;
d) 상기 c)의 w/o 에멀견을 40~150°C로 가열하면서 수상 용액 상의 가교제와 MPC와의 가교반웅을 진행시키는 단계; 및 d) heating the w/o emulsion of c) to 40-150 ° C while conducting a cross-linking reaction between the cross-linking agent in the aqueous solution and MPC; and
e) 상기 d)의 w/o 에멀견으로부터 MPC 구형 하이드로겔 입자를 회수하는 단 계. e) Recovering the MPC spherical hydrogel particles from the w/o emulsion of d) above.
【청구항 12】 【Claim 12】
저 U항 내지 제 9항 중 어느 한 항의 MPC 구형 하이드로겔 입자를 포함하는 화 장료 조성물. A cosmetic composition comprising the MPC spherical hydrogel particles of any one of claims U to 9.
【청구항 13】 【Claim 13】
제 12항에 있어서, 상기 조성물은 오일상, 또는 w/o 또는 o/w 유화형의 조성 물임을 특징으로 하는 화장료 조성물. The cosmetic composition according to claim 12, wherein the composition is in the form of an oil or a w/o or o/w emulsion type.
【청구항 14] [Claim 14]
제 13항에 있어서, 상기 조성물은 계면활성제를 포함하지 않음을 특징으로 하 는 화장료 조성물.
The cosmetic composition of claim 13, wherein the composition does not contain a surfactant.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20130130754 | 2013-10-31 | ||
KR10-2013-0130754 | 2013-10-31 | ||
KR1020140149695A KR102163884B1 (en) | 2013-10-31 | 2014-10-31 | Spherical hydrogel particles using MPC and water-soluble crosslinking agent |
KR10-2014-0149695 | 2014-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015065100A1 true WO2015065100A1 (en) | 2015-05-07 |
Family
ID=53004605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2014/010359 WO2015065100A1 (en) | 2013-10-31 | 2014-10-31 | Spherical hydrogel particles using mpc and water-soluble crosslinking agent |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2015065100A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113683790A (en) * | 2021-08-24 | 2021-11-23 | 塔里木大学 | Porous hydrogel and preparation method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100203004A1 (en) * | 2007-10-31 | 2010-08-12 | L'oreal | Cosmetic composition containing a tensioning agent and an acrylic polymer |
US20120321585A1 (en) * | 2009-09-30 | 2012-12-20 | University Of Ottawa | Crosslinked Hydrogels and Related Method of Preparation |
KR20130027398A (en) * | 2011-01-07 | 2013-03-15 | 주식회사 케이씨아이 | Crosslinked copolymers based on monomers containing phosphorylcholine-like groups, and their cosmetic formulations |
-
2014
- 2014-10-31 WO PCT/KR2014/010359 patent/WO2015065100A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100203004A1 (en) * | 2007-10-31 | 2010-08-12 | L'oreal | Cosmetic composition containing a tensioning agent and an acrylic polymer |
US20120321585A1 (en) * | 2009-09-30 | 2012-12-20 | University Of Ottawa | Crosslinked Hydrogels and Related Method of Preparation |
KR20130027398A (en) * | 2011-01-07 | 2013-03-15 | 주식회사 케이씨아이 | Crosslinked copolymers based on monomers containing phosphorylcholine-like groups, and their cosmetic formulations |
Non-Patent Citations (2)
Title |
---|
ISHIHARA, KAZUHIKO ET AL.: "Preparation of phospholipid polylmers and their properties as polymer hydrogel membranes", POLYMER JOURNAL., vol. 22, no. 5, 1990, pages 355 - 360 * |
LIU, WENGUANG ET AL.: "Collagen-phosphorylcholine interpenetrating network hydrogels as corneal substitutes", BIOMATERIALS, vol. 30, no. 8, 2009, pages 1551 - 1559 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113683790A (en) * | 2021-08-24 | 2021-11-23 | 塔里木大学 | Porous hydrogel and preparation method and application thereof |
CN113683790B (en) * | 2021-08-24 | 2023-12-22 | 塔里木大学 | Porous hydrogel and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100852944B1 (en) | Preparation method of chemically cross-linked hyaluronic acid hydrogel nanoparticles | |
TWI719772B (en) | Method for producing cellulose acetate-containing particles, cosmetic composition and cellulose acetate-containing particles | |
CA2805430C (en) | Method for preparing microspheres and microspheres produced thereby | |
Lasoń et al. | Influence of process parameters on properties of Nanostructured Lipid Carriers (NLC) formulation | |
CN103167868B (en) | Hydrogel particle being coated with lipid and preparation method thereof | |
WO2019139380A1 (en) | Vitamin c-containing polycaprolactone microsphere filler and preparation method therefor | |
JP6211680B2 (en) | Pull-langer and its production method and use | |
JP5546291B2 (en) | W / O / W type Pickering emulsion and method for preparing the same | |
JP2009079030A (en) | Oily gel composition and method of preparation of emulsified composition | |
Phaechamud et al. | Viscoelastic and thermal properties of doxycycline hyclate-loaded bleached shellac in situ-forming gel and–microparticle | |
JP2006519779A (en) | Microencapsulation system and its application | |
JP2011178768A (en) | O/w/o pickering emulsion | |
JP3051215B2 (en) | Hyaluronic acid gel and method for producing the same | |
KR102163884B1 (en) | Spherical hydrogel particles using MPC and water-soluble crosslinking agent | |
JP4810129B2 (en) | Non-aqueous emulsion composition | |
JP5784619B2 (en) | Method for wetting powders containing benzoyl peroxide | |
JP2002504425A (en) | Matrix for producing microparticles or nanoparticles, method for producing said particles and particles obtained | |
CN110151986A (en) | Biological degradable water packet water-in-oil emulsion and preparation method thereof | |
WO2015065100A1 (en) | Spherical hydrogel particles using mpc and water-soluble crosslinking agent | |
CN108938565A (en) | A kind of trans-cinnamic aldehyde nano-emulsion and preparation method thereof | |
KR20190079276A (en) | Anti-aging cosmetics with nanoparticles-ingredient that solubilized insoluble oligoanionic acid and manufacturing method for anti-aging cosmetics | |
Jose et al. | Organogels: A versatile drug delivery tool in pharmaceuticals | |
KR101032623B1 (en) | Double capsule comprised of pH-responsive copolymer and phospholipid, and cosmetic composition containing the capsule | |
US8551916B2 (en) | Method for preparation of aqueous emulsion using interfacially active organic compound as emulsifying agent | |
CN113426389B (en) | Preparation method of alcohol soluble protein microcapsule and product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14857851 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1)EPC DATED 22.08.2016 (EPO FORM 1205A). |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14857851 Country of ref document: EP Kind code of ref document: A1 |